Denosumab-Associated Osteonecrosis of the Jaw: FDG PET/CT Findings in a Case Report

Authors

  • Saloni Rajkotia Department of Nuclear Medicine, The Gujarat Cancer and Research Institute, Ahmedabad, India
  • Ritesh Suthar Department of Nuclear Medicine, The Gujarat Cancer and Research Institute, Ahmedabad, India https://orcid.org/0000-0002-9383-069X (unauthenticated)
  • Abhishek Palsapure Department of Nuclear Medicine, The Gujarat Cancer and Research Institute, Ahmedabad, India

DOI:

https://doi.org/10.59667/sjoranm.v13i1.18

Keywords:

MANDIBLE, DENOSUMAB, OSTEONECROSIS, FDG PET/CT

Abstract

A 77-year-old woman with stage IV non-small cell lung cancer receiving denosumab for the prevention of skeletal-related events presented with two months of worsening jaw pain and swelling accompanied by low-grade fever. FDG PET/CT demonstrated increased uptake in the left mandible with cortical thickening, marrow sclerosis and surrounding soft-tissue thickening and oedema. Osteonecrosis of the jaw was suspected in the clinical context and subsequently confirmed by an oral surgeon. Conservative treatment comprised antibiotics, oral hygiene measures and pain management. This case illustrates the metabolic and structural findings of jaw osteonecrosis during denosumab therapy. FDG uptake is nonspecific and requires correlation with clinical findings and structural imaging.

References

Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci. 2011;1218(1):38–46. https://doi.org/10.1111/j.1749-6632.2010.05768.x DOI: https://doi.org/10.1111/j.1749-6632.2010.05768.x

Marx RE. A Decade of Bisphosphonate Bone Complications: What It Has Taught Us About Bone Physiology. Int J Oral Maxillofac Implants. 2014;29(2):247. https://doi.org/10.11607/jomi.te61 DOI: https://doi.org/10.11607/jomi.te61

Glaudemans A, et al. The Use of 18F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases. J Immunol Res. 2013;2013:623036. https://doi.org/10.1155/2013/623036 DOI: https://doi.org/10.1155/2013/623036

Dinnoo A, et al. 18F-FDG PET/CT for early response assessment of jaw osteoradionecrosis after the PENTOCLO protocol: A promising imaging modality. J Stomatol Oral Maxillofac Surg. 2022;123(4):e192–e198. https://doi.org/10.1016/j.jormas.2021.11.005 DOI: https://doi.org/10.1016/j.jormas.2021.11.005

SJORANM article cover, Vol. 13 No. 1 (2024). Holographic symbolic illustration for article 47.

Published

2024-11-24

Issue

Section

Case reports

How to Cite

Rajkotia, S., Suthar, R., & Palsapure, A. (2024). Denosumab-Associated Osteonecrosis of the Jaw: FDG PET/CT Findings in a Case Report. Swiss Journal of Radiology and Nuclear Medicine, 13(1), 20-22. https://doi.org/10.59667/sjoranm.v13i1.18

Share

Similar Articles

21-30 of 47

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)